futurehealth.com tirzepatide FuturHealth: GLP-1s + Meals = Better Results 02/27/2025 Experience the Power of Tirzepatide:

Tapering Slowly to Maintain Weight Loss Without Relapse Gradual reduction helps ease the body off medication, reducing relapse risks

If endogenous glutaredoxin availability or activity is limiting, then rxYFP may become oxidized by other processes (e.g., by ROS from the respiratory chain) and thus lose its ability to act as a specific reporter for the glutathione redox couple

Clinical Results and Weight Loss Data Retatrutide has produced some of the most impressive weight loss data seen to date: 11.5% to 16.8% weight loss in type 2 diabetes trials Up to 24% weight loss in obesity studies at 48 weeks Average loss of over 36 pounds in 40 weeks at higher doses In certain populations, including individuals with obesity and joint issues, weight loss exceeded 70 pounds over the course of a year

168 SvenningssonP.WirdefeldtK.YinL.FangF.MarkakiI.EfendicS.et al (2016)